Literature DB >> 20547972

Brain microglial cytokines in neurogenic hypertension.

Peng Shi1, Carlos Diez-Freire, Joo Yun Jun, Yanfei Qi, Michael J Katovich, Qiuhong Li, Srinivas Sriramula, Joseph Francis, Colin Sumners, Mohan K Raizada.   

Abstract

Accumulating evidence indicates a key role of inflammation in hypertension and cardiovascular disorders. However, the role of inflammatory processes in neurogenic hypertension remains to be determined. Thus, our objective in the present study was to test the hypothesis that activation of microglial cells and the generation of proinflammatory cytokines in the paraventricular nucleus (PVN) contribute to neurogenic hypertension. Intracerebroventricular infusion of minocycline, an anti-inflammatory antibiotic, caused a significant attenuation of mean arterial pressure, cardiac hypertrophy, and plasma norepinephrine induced by chronic angiotensin II infusion. This was associated with decreases in the numbers of activated microglia and mRNAs for interleukin (IL) 1beta, IL-6, and tumor necrosis factor-alpha, and an increase in the mRNA for IL-10 in the PVN. Overexpression of IL-10 induced by recombinant adenoassociated virus-mediated gene transfer in the PVN mimicked the antihypertensive effects of minocycline. Furthermore, acute application of a proinflammatory cytokine, IL-1beta, into the left ventricle or the PVN in normal rats resulted in a significant increase in mean arterial pressure. Collectively, this indicates that angiotensin II induced hypertension involves activation of microglia and increases in proinflammatory cytokines in the PVN. These data have significant implications on the development of innovative therapeutic strategies for the control of neurogenic hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20547972      PMCID: PMC2929640          DOI: 10.1161/HYPERTENSIONAHA.110.150409

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  28 in total

1.  Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension.

Authors:  Christian Stumpf; Stefan John; Jelena Jukic; Atilla Yilmaz; Dorette Raaz; Roland E Schmieder; Werner G Daniel; Christoph D Garlichs
Journal:  J Hypertens       Date:  2005-05       Impact factor: 4.844

Review 2.  The sympathetic control of blood pressure.

Authors:  Patrice G Guyenet
Journal:  Nat Rev Neurosci       Date:  2006-05       Impact factor: 34.870

3.  Chronic low-dose angiotensin II infusion increases venomotor tone by neurogenic mechanisms.

Authors:  Andrew J King; Gregory D Fink
Journal:  Hypertension       Date:  2006-09-25       Impact factor: 10.190

Review 4.  Clinical potential of minocycline for schizophrenia.

Authors:  Tsuyoshi Miyaoka
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-10       Impact factor: 4.388

Review 5.  Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives.

Authors:  Shereeni J Veerasingham; Mohan K Raizada
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontaneously hypertensive rats.

Authors:  Hongwei Li; Yongxin Gao; Yanfei Qi; Michael J Katovich; Nan Jiang; Leah N Braseth; Deborah A Scheuer; Peng Shi; Colin Sumners
Journal:  FASEB J       Date:  2008-06-05       Impact factor: 5.191

7.  Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.

Authors:  Maria Nikodemova; Jyoti J Watters; Samuel J Jackson; Shaun K Yang; Ian D Duncan
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

8.  Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction.

Authors:  Yang Yu; Zhi-Hua Zhang; Shun-Guang Wei; Yi Chu; Robert M Weiss; Donald D Heistad; Robert B Felder
Journal:  Circ Res       Date:  2007-06-14       Impact factor: 17.367

9.  Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy.

Authors:  Srinivas Sriramula; Masudul Haque; Dewan S A Majid; Joseph Francis
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

10.  TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats.

Authors:  Anuradha Guggilam; Masudul Haque; Edmund Kenneth Kerut; Elizabeth McIlwain; Pamela Lucchesi; Inder Seghal; Joseph Francis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-04-06       Impact factor: 4.733

View more
  170 in total

Review 1.  The central nervous system and inflammation in hypertension.

Authors:  Paul J Marvar; Heinrich Lob; Antony Vinh; Faresa Zarreen; David G Harrison
Journal:  Curr Opin Pharmacol       Date:  2010-12-31       Impact factor: 5.547

Review 2.  Central neuromodulatory pathways regulating sympathetic activity in hypertension.

Authors:  Alexander Gabor; Frans H H Leenen
Journal:  J Appl Physiol (1985)       Date:  2012-07-05

Review 3.  Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.

Authors:  Jasenka Zubcevic; Monica M Santisteban; Teresa Pitts; David M Baekey; Pablo D Perez; Donald C Bolser; Marcelo Febo; Mohan K Raizada
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

4.  Gut dysbiosis is linked to hypertension.

Authors:  Tao Yang; Monica M Santisteban; Vermali Rodriguez; Eric Li; Niousha Ahmari; Jessica Marulanda Carvajal; Mojgan Zadeh; Minghao Gong; Yanfei Qi; Jasenka Zubcevic; Bikash Sahay; Carl J Pepine; Mohan K Raizada; Mansour Mohamadzadeh
Journal:  Hypertension       Date:  2015-04-13       Impact factor: 10.190

5.  Ang II-salt hypertension depends on neuronal activity in the hypothalamic paraventricular nucleus but not on local actions of tumor necrosis factor-α.

Authors:  Megan E Bardgett; Walter W Holbein; Myrna Herrera-Rosales; Glenn M Toney
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

Review 6.  The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension.

Authors:  David G Harrison
Journal:  J Am Soc Hypertens       Date:  2013 Jan-Feb

Review 7.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

9.  Astrocytes Contribute to Angiotensin II Stimulation of Hypothalamic Neuronal Activity and Sympathetic Outflow.

Authors:  Javier E Stern; Sookjin Son; Vinicia C Biancardi; Hong Zheng; Neeru Sharma; Kaushik P Patel
Journal:  Hypertension       Date:  2016-10-03       Impact factor: 10.190

10.  Systemic administration of pentoxifylline attenuates the development of hypertension in renovascular hypertensive rats.

Authors:  Anthony Setiadi; Willian S Korim; Clive N May; Song T Yao
Journal:  Hypertens Res       Date:  2020-02-14       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.